Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript

TheMotleyFool

0 0

Image source: The Motley Fool.

Karyopharm Therapeutics (NASDAQ: KPTI)
Q3 2023 Earnings Call
Nov 02, 2023, 8:00 a.m. ET

Operator

Source Fool.com

Karyopharm Therapeutics Inc. Stock

Karyopharm Therapeutics Inc. dominated the market today, gaining €0.045 (4.380%).
With 7 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.05 € the target price of 3 € shows a potential of 185.58% for Karyopharm Therapeutics Inc. which would more than double the current price.

Like: 0

KPTI

Share